Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 129.04 Million | 140.72 Million | 80.61 Million | 455.78 Million | 81.42 Million | 81.2 Million |
| Net Income | -60.95 Million | 24.5 Million | 67.25 Million | 352.26 Million | 73.04 Million | 78.23 Million |
| Depreciation & Amortization | 58.12 Million | 51.24 Million | 40.49 Million | 17.68 Million | 13.88 Million | 14.09 Million |
| Deferred income taxes | 8.21 Million | -8.46 Million | -4.26 Million | 2.69 Million | -410.05 Thousand | -2.51 Million |
| Stock-based compensation | 3.01 Million | 7.29 Million | - | - | - | - |
| Change in working capital | -9.02 Million | 36.72 Million | -73.08 Million | 48.36 Million | -24.57 Million | -21.35 Million |
| Other non-cash items | 26.42 Million | 29.42 Million | 45.94 Million | 37.47 Million | 19.07 Million | 10.23 Million |
| Investing Cash Flow | -190.24 Million | -496.4 Million | -193.16 Million | -204.88 Million | -149.28 Million | -121.85 Million |
| Investments in PPE | -220.33 Million | -211.79 Million | -163.41 Million | -68.44 Million | -46.99 Million | -99.81 Million |
| Acquisitions | -1.02 Million | -18.22 Million | 3.61 Million | -110.69 Million | 22.73 Thousand | 4.28 Million |
| Investment purchases | -113.6 Million | -332.85 Million | -84.5 Million | -159.19 Million | -35 Million | -33.89 Million |
| Sales/Maturities of investments | 144.68 Million | 43.74 Million | 63.42 Million | 135.49 Million | 5.03 Million | 7.82 Million |
| Other Investing Activities | 31.11 Million | 22.72 Million | -12.29 Million | -2.03 Million | -72.34 Million | -248.45 Thousand |
| Financing Cash Flow | 117.55 Million | 486.69 Million | -44.5 Million | 37.37 Million | 64.61 Million | 40.73 Million |
| Debt repayment | -203.63 Million | -162.29 Million | -122.68 Million | -146.68 Million | -94.75 Million | -46.84 Million |
| Dividends payments | -35.15 Million | -35.13 Million | -58.43 Million | -29.21 Million | -14.6 Million | -9.86 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -34.38 Million | 689.83 Million | 136.53 Million | 217.23 Million | 179.67 Million | 97.44 Million |
| Accounts receivables | -42.69 Million | -58.26 Million | -50.71 Million | -11.85 Million | -2.54 Million | -19.84 Million |
| Accounts payables | 52.23 Million | 109.61 Million | 27.84 Million | 109.58 Million | -37.69 Million | 11.05 Million |
| Inventory | -26.78 Million | -6.15 Million | -45.94 Million | -52.06 Million | 16.06 Million | -10.05 Million |
| Other working capital | -4.88 Million | -8.46 Million | -4.26 Million | 2.69 Million | -410.05 Thousand | -11.3 Million |
| Cash at beginning of period | 402.41 Million | 266.61 Million | 424.88 Million | 146.78 Million | 149.39 Million | 149.66 Million |
| Cash at end of period | 459.94 Million | 402.41 Million | 266.61 Million | 424.88 Million | 146.78 Million | 149.39 Million |
| Capital Expenditure | -220.33 Million | -211.79 Million | -163.41 Million | -68.44 Million | -46.99 Million | -99.81 Million |
| Effect of forex changes on cash | 1.18 Million | 4.78 Million | -1.21 Million | -10.17 Million | 636.56 Thousand | -364.16 Thousand |
| Net cash flow / Change in cash | 57.53 Million | 135.79 Million | -158.27 Million | 278.1 Million | -2.6 Million | -273.45 Thousand |
| Free Cash Flow | -91.28 Million | -71.07 Million | -82.79 Million | 387.33 Million | 34.42 Million | -18.61 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.12 Million | -6.14 Million | 3.62 Million | -60.95 Million | -129.46 Million | 5.42 Million |
| Depreciation & Amortization | - | 18.15 Million | 18.15 Million | 58.12 Million | 58.12 Million | -30.02 Million |
| Deferred income taxes | - | - | - | 8.21 Million | - | - |
| Stock-based compensation | - | - | - | 3.01 Million | 3.01 Million | - |
| Change in working capital | - | - | - | -9.02 Million | -74.36 Million | 46.73 Million |
| Other non-cash items | 9.96 Million | 11.05 Million | -20.84 Million | 26.42 Million | 224.2 Million | 32.53 Million |
| Investing Cash Flow | -25.34 Million | -16.37 Million | -748.87 Thousand | -190.24 Million | -54.83 Million | -35.27 Million |
| Investments in PPE | -23.81 Million | -17 Million | -42.75 Million | -220.33 Million | -54.88 Million | -35.26 Million |
| Acquisitions | 784.50 | 209.2 Thousand | 2646.00 | -1.02 Million | -9.9 Million | - |
| Investment purchases | -23.62 Million | - | -24.9 Million | -113.6 Million | -113.6 Million | - |
| Sales/Maturities of investments | 22.09 Million | 418.07 Thousand | 66.9 Million | 144.68 Million | 113.63 Million | - |
| Other Investing Activities | 784.50 | 209.2 Thousand | 49.49 Million | 31.11 Million | 43.87 Thousand | -7410.00 |
| Financing Cash Flow | -101.14 Million | 28.93 Million | 105.34 Million | 117.55 Million | -20.16 Million | 813.59 Thousand |
| Debt repayment | -79 Million | -43.75 Million | -108.5 Million | -203.63 Million | -17.59 Million | -25.72 Million |
| Dividends payments | -8.91 Million | -7.63 Million | -3.35 Million | -35.15 Million | -35.15 Million | -3.4 Million |
| Common Stock Repurchased | 20 Million | -20 Million | - | - | -2.35 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.22 Million | -7.18 Million | -3.15 Million | -34.38 Million | -31.06 Million | 29.94 Million |
| Accounts receivables | - | - | - | -42.69 Million | -42.69 Million | 20.72 Million |
| Accounts payables | - | - | - | 52.23 Million | - | - |
| Inventory | - | - | - | -26.78 Million | -26.78 Million | 26.01 Million |
| Other working capital | - | - | - | -4.88 Million | -4.88 Million | -1.78 Million |
| Cash at beginning of period | 546.61 Million | 546.4 Million | 490.99 Million | 402.41 Million | 458 Million | 438.43 Million |
| Cash at end of period | 417.08 Million | 546.61 Million | 591.84 Million | 459.94 Million | 459.94 Million | 458 Million |
| Capital Expenditure | -23.81 Million | -17 Million | -42.75 Million | -220.33 Million | -54.88 Million | -35.26 Million |
| Effect of forex changes on cash | -1.88 Million | 1.32 Million | -918.54 Thousand | 1.18 Million | -1.55 Million | -640.89 Thousand |
| Net cash flow / Change in cash | -129.53 Million | 215.24 Thousand | 100.85 Million | 57.53 Million | 1.94 Million | 19.56 Million |
| Free Cash Flow | -24.97 Million | -30.24 Million | -59.97 Million | -91.28 Million | 23.61 Million | 19.39 Million |
PSSR
WALMEX
NYAX
2646
2462
5596